Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WV › Keyser › NPI 1912979873
Hospital

Potomac Valley Hospital of W Va , INC

Potomac Valley Hospital of W Va , INC was paid $10.97M by Medicaid between Jan 2018 and Dec 2024, across 182 billing codes. Its largest line is 99283, emergency room visit (moderate) — 10% of everything it billed.

33Billing provider infoPOTOMAC VALLEY HOSPITAL OF W VA , INC
KEYSER, WV 26726
33aNPI1912979873assigned 02/06/2006
33bProvider typeCritical Access Hospital
28Total paid$10.97M
24GClaims238,415
24DCodes billed182
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in West Virginia

Rank by total paid#5 of 24
Median peer was paid$3.57M
This provider vs. median3.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201829,402$1.26M
201930,337$1.51M
202040,237$2.11M
202141,896$2.38M
202226,954$1.27M
202339,088$1.42M
2024incomplete30,501$1.03M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 13,005 10,244 $1.10M
80053 Comprehensive metabolic panel 9.7% 16,544 13,146 $1.07M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 8.4% 9,487 7,077 $927K
74177 Computed tomography, abdomen and pelvis; with contrast material 5.9% 1,119 975 $652K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 5.6% 4,195 3,597 $619K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.5% 3,898 2,754 $490K
74176 Computed tomography, abdomen and pelvis; without contrast material 4.5% 1,278 1,150 $490K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.9% 19,537 15,081 $323K
70450 Computed tomography, head or brain; without contrast material 2.7% 1,998 1,777 $297K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.3% 4,474 3,842 $253K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.1% 6,171 4,796 $231K
84484 1.9% 4,749 3,325 $213K
170 more codes
96361 Intravenous infusion, hydration; each additional hour 1.6% 1,507 $178K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.5% 2,128 $163K
81001 1.5% 7,294 $161K
96375 Therapeutic injection; each additional sequential IV push 1.4% 4,494 $155K
84443 Thyroid stimulating hormone (TSH) 1.4% 4,730 $151K
80061 Lipid panel 1.4% 4,692 $150K
71046 Radiologic examination, chest; 2 views 1.3% 3,272 $146K
80048 Basic metabolic panel (calcium, ionized) 1.3% 3,200 $139K
36415 Collection of venous blood by venipuncture 1.2% 14,020 $134K
71045 Radiologic examination, chest; single view 1.1% 3,754 $125K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.1% 4,928 $116K
83605 1.1% 3,572 $115K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,533 $105K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,077 $81K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 302 $79K
83036 Hemoglobin; glycosylated (A1C) <1% 3,358 $69K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 492 $66K
83735 <1% 3,448 $65K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 928 $65K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,258 $64K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,364 $60K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 424 $59K
87631 <1% 336 $59K
87040 <1% 1,107 $58K
99213 Doctor's office visit, returning patient (routine) <1% 6,441 $57K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,134 $55K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 806 $55K
83690 <1% 2,938 $50K
83880 <1% 1,211 $50K
80305 <1% 923 $50K
J7120 Ringers lactate infusion, up to 1000 cc <1% 848 $49K
96376 <1% 1,044 $48K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,907 $46K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,627 $43K
71250 <1% 243 $42K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,937 $40K
85610 <1% 2,826 $40K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,165 $40K
99214 Doctor's office visit, returning patient (more involved) <1% 6,482 $40K
82803 <1% 1,018 $39K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 297 $38K
82550 <1% 2,064 $36K
87081 <1% 1,251 $33K
72125 Computed tomography, cervical spine; without contrast material <1% 136 $32K
77067 Screening mammography, bilateral, including computer-aided detection <1% 372 $31K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 629 $31K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 194 $30K
97602 <1% 322 $30K
29581 <1% 788 $28K
85730 <1% 1,260 $27K
84439 <1% 1,123 $22K
85379 <1% 968 $22K
96127 <1% 368 $21K
77063 Screening digital breast tomosynthesis, bilateral <1% 372 $20K
85027 <1% 1,336 $20K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 731 $19K
81025 <1% 716 $17K
94060 <1% 126 $17K
90834 Psychotherapy session, about 45 minutes <1% 188 $17K
82248 <1% 2,016 $17K
82607 <1% 527 $17K
87077 <1% 1,016 $17K
G0378 Hospital observation service, per hour <1% 179 $17K
82330 <1% 800 $15K
87186 <1% 737 $15K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,373 $15K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 417 $15K
85007 <1% 571 $15K
82150 <1% 364 $15K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 326 $15K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 132 $14K
36600 <1% 741 $14K
90837 Psychotherapy session, about an hour <1% 106 $13K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,471 $13K
73030 <1% 236 $12K
97035 <1% 259 $12K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 145 $11K
72110 <1% 122 $11K
94760 <1% 481 $11K
80050 General health panel <1% 85 $10K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 97 $10K
73562 <1% 206 $10K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) <1% 156 $10K
73630 <1% 192 $9K
73610 <1% 164 $9K
71275 Computed tomographic angiography, chest, with contrast material <1% 48 $8K
82805 <1% 317 $8K
84100 <1% 164 $7K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 12 $6K
99203 Doctor's office visit, new patient (routine) <1% 525 $6K
97014 <1% 143 $5K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 205 $5K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 559 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 35 $5K
82947 <1% 407 $5K
85651 <1% 398 $4K
84481 <1% 71 $4K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 85 $4K
94729 <1% 154 $4K
88142 <1% 182 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 177 $4K
84466 <1% 126 $4K
97162 <1% 40 $4K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 44 $3K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 74 $3K
94727 <1% 37 $3K
73130 <1% 57 $3K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 14 $3K
94726 <1% 61 $3K
81002 <1% 496 $3K
90792 Psychiatric diagnostic evaluation with medical services <1% 18 $2K
73564 <1% 30 $2K
J3490 Unclassified drugs <1% 1,271 $2K
99204 Doctor's office visit, new patient (more involved) <1% 300 $2K
84520 <1% 163 $2K
83540 <1% 155 $2K
20610 <1% 54 $2K
74018 <1% 28 $2K
76536 <1% 15 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 53 $2K
11721 <1% 122 $2K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 442 $2K
J2704 Injection, propofol, 10 mg <1% 188 $2K
90791 Psychiatric diagnostic evaluation <1% 16 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 73 $2K
87807 <1% 21 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 15 $1K
84132 <1% 187 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 148 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 102 $1K
84295 <1% 170 $1K
82435 <1% 170 $1K
82565 <1% 35 $1K
87147 <1% 32 $1K
74019 <1% 19 $1K
86140 <1% 153 $983.43
82570 <1% 108 $969.02
84145 <1% 153 $934.74
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 33 $899.37
96367 <1% 18 $887.72
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 287 $871.96
J0690 Injection, cefazolin sodium, 500 mg <1% 52 $861.04
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 19 $829.59
82728 <1% 24 $696.25
84460 <1% 14 $668.94
84450 <1% 14 $668.94
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 73 $634.24
80051 <1% 16 $623.65
82043 <1% 40 $498.66
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 91 $454.93
84703 <1% 30 $444.86
G0475 Hiv antigen/antibody, combination assay, screening <1% 14 $426.38
84436 <1% 12 $360.57
80179 <1% 12 $342.09
J1650 Injection, enoxaparin sodium, 10 mg <1% 63 $318.74
86850 <1% 27 $318.06
86803 <1% 13 $303.48
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 49 $284.58
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 36 $247.20
87205 <1% 15 $181.84
86900 <1% 13 $134.30
85018 <1% 13 $133.82
J2060 Injection, lorazepam, 2 mg <1% 44 $131.61
86901 <1% 13 $105.70
J3010 Injection, fentanyl citrate, 0.1 mg <1% 108 $48.61
J7060 5% dextrose/water (500 ml = 1 unit) <1% 53 $45.72
J1030 Injection, methylprednisolone acetate, 40 mg <1% 16 $44.19
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 45 $37.86
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 76 $14.82
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 0% 27 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCBEE, HAROLD (OWNER)
Same official

Other billing entities under MCBEE, HAROLD

Full network →
ProviderLocationPaid
Potomac Valley Hospital of W Va, INCPiedmont, WV$576K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.